David Bharucha
Technik-/Wissenschafts-/F&E-Leiter bei MILESTONE PHARMACEUTICALS INC.
Vermögen: 23 890 $ am 30.04.2024
Profil
David B.
Bharucha is currently the Chief Medical Officer at Milestone Pharmaceuticals, Inc. Prior to this, he worked as the VP-Clinical Development, Research & Development at Allergan Ltd.
(Ireland) from 2018 to 2021.
Dr. Bharucha received his undergraduate degree from Haverford College and his doctorate degree from The University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 15 120 ( 0,03% ) | 23 890 $ | 30.04.2024 |
Aktive Positionen von David Bharucha
| Unternehmen | Position | Beginn |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.02.2022 |
Ehemalige bekannte Positionen von David Bharucha
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von David Bharucha
| The University of Chicago | Doctorate Degree |
| Haverford College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
